NEU 0.73% $19.06 neuren pharmaceuticals limited

E & P stock focus note came out today- $24.40 valuation. "Our...

  1. 1,543 Posts.
    lightbulb Created with Sketch. 290
    E & P stock focus note came out today- $24.40 valuation. "Our base case valuation of $24.40 is derived from generally conservative or mid-range assumptions and allows for upside from future derisking events"

    The other interesting point is their valuation on NNZ-2591 at $21.5 if successful:
    "We make no changes to our model and we retain our Speculative Buy rating. Our price target remains at A$24.4 per share with a sum
    of the parts risk-adjusted DCF valuation (Figure 4). As a thought exercise, if NNZ-2591 is successful across all four current indications
    under development by NEU, we believe that asset's opportunity to be worth ~A$21.5 per share (see Figure 5)"
    Last edited by TripAces: 17/01/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.06
Change
-0.140(0.73%)
Mkt cap ! $2.433B
Open High Low Value Volume
$18.76 $19.35 $18.71 $7.893M 414.4K

Buyers (Bids)

No. Vol. Price($)
5 5037 $19.00
 

Sellers (Offers)

Price($) Vol. No.
$19.16 881 1
View Market Depth
Last trade - 16.10pm 01/05/2024 (20 minute delay) ?
Last
$19.11
  Change
-0.140 ( 0.78 %)
Open High Low Volume
$18.80 $19.34 $18.73 92009
Last updated 15.59pm 01/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.